• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Diradylglycerols Diacylglycerols

Introduction to 1,3-Dipalmitin-D62 (CAS No: 2692624-34-1)

1,3-Dipalmitin-D62, identified by the Chemical Abstracts Service (CAS) number 2692624-34-1, is a specialized lipid compound that has garnered significant attention in the field of biochemical research and pharmaceutical development. This compound belongs to the class of diacylglycerols, specifically featuring palmitic acid as the acyl groups at thesn-1 and sn-3 positions of glycerol. The "D62" designation indicates a deuterium-labeled version, where hydrogen atoms have been partially replaced by deuterium, making it a valuable tool for metabolic studies and isotope labeling experiments.

The structure of 1,3-Dipalmitin-D62 consists of a glycerol backbone with two long-chain fatty acids, palmitic acid (C16H33COOH), attached at thesn-1 and sn-3 positions. This configuration mimics natural triglycerides found in biological systems, such as those in human adipose tissue and dairy products. The deuterium labeling at specific positions enhances the compound's utility in tracing metabolic pathways and studying lipid metabolism in vitro and in vivo.

In recent years, 1,3-Dipalmitin-D62 has been extensively utilized in research focused on understanding the role of lipids in cellular signaling and energy storage. Studies have demonstrated its potential applications in investigating lipid droplet formation and dynamics within cells. The stable isotope labeling provided by deuterium allows researchers to track the fate of this compound using mass spectrometry techniques, providing insights into its incorporation into metabolic pathways.

One of the most compelling aspects of 1,3-Dipalmitin-D62 is its application in drug formulation and delivery systems. Lipid-based nanoparticles are increasingly being explored as carriers for therapeutic agents due to their biocompatibility and ability to enhance drug solubility and targeting. The use of labeled lipids like 1,3-Dipalmitin-D62 enables researchers to optimize nanoparticle formulations by monitoring lipid degradation and distribution within biological systems.

Furthermore, advancements in analytical chemistry have facilitated the precise characterization of 1,3-Dipalmitin-D62 using techniques such as nuclear magnetic resonance (NMR) spectroscopy and infrared (IR) spectroscopy. These methods allow for detailed structural elucidation and confirmation of the deuterium labeling, ensuring high purity and consistency in experimental applications.

The pharmaceutical industry has also shown interest in 1,3-Dipalmitin-D62 for its potential role in developing lipid-based drug formulations. By incorporating labeled lipids into drug delivery systems, researchers can better understand how drugs are metabolized and distributed within the body. This information is crucial for improving drug efficacy and minimizing side effects.

Recent studies have highlighted the importance of 1,3-Dipalmitin-D62 in understanding metabolic disorders such as obesity and diabetes. Lipid metabolism plays a critical role in these conditions, and labeled lipids provide a means to study how disruptions in lipid homeostasis contribute to disease progression. By using 1,3-Dipalmitin-D62, researchers can investigate the impact of diet and exercise on lipid metabolism, offering potential insights into therapeutic interventions.

The biotechnology sector has also leveraged 1,3-Dipalmitin-D62 for developing advanced biochemical assays. These assays are designed to measure key enzymes involved in lipid metabolism, such as lipases and acyl-CoA synthetases. The use of labeled substrates like 1,3-Dipalmitin-D62 enhances sensitivity and accuracy in these measurements, leading to more reliable data for drug discovery programs.

In conclusion,1,3-Dipalmitin-D62 (CAS No: 2692624-34-1) is a versatile compound with significant applications in biochemical research, pharmaceutical development, and biotechnology. Its unique structure as a deuterium-labeled diacylglycerol makes it an invaluable tool for studying lipid metabolism, drug delivery systems, and metabolic disorders. As research continues to uncover new applications for this compound,1,3-Dipalmitin-D62 is poised to play an even greater role in advancing our understanding of biological processes and developing innovative therapeutic solutions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)